TD Cowen cuts Artiva Biotherapeutics to hold from buy
ARTV•TD Cowen cut its rating on Artiva Biotherapeutics to hold from buy.
Related News
Ripple and Robinhood partner to power the next generation of finance
XRP•
Agi board approves repurchase program for up to 3 million Class A shares
AGBK•
US September single-family home sales data
SPY•
Cloudera launches blueprints for enterprise AI deployment
NVDA•
Oil falls as Middle East talks outweigh concern over fresh strikes
USO•